| __timestamp | Ligand Pharmaceuticals Incorporated | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9136000 | 3243000 |
| Thursday, January 1, 2015 | 5807000 | 2472000 |
| Friday, January 1, 2016 | 5571000 | 2548000 |
| Sunday, January 1, 2017 | 5366000 | 19623000 |
| Monday, January 1, 2018 | 6337000 | 30421000 |
| Tuesday, January 1, 2019 | 11347000 | 32793999 |
| Wednesday, January 1, 2020 | 30419000 | 28304000 |
| Friday, January 1, 2021 | 62176000 | 620000 |
| Saturday, January 1, 2022 | 52827000 | 755000 |
| Sunday, January 1, 2023 | 35049000 | 1322000 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology, understanding financial metrics like the cost of revenue is crucial. Ligand Pharmaceuticals Incorporated and Viridian Therapeutics, Inc. offer a fascinating case study. From 2014 to 2023, Ligand Pharmaceuticals saw a dramatic increase in its cost of revenue, peaking in 2021 with a staggering 580% rise from its 2014 figures. This surge reflects Ligand's aggressive expansion and investment in research and development.
Conversely, Viridian Therapeutics experienced a volatile journey. After a significant spike in 2019, reaching nearly 10 times its 2014 cost, the company managed to reduce its expenses drastically by 2021. This fluctuation highlights Viridian's strategic shifts and market adaptations.
These trends underscore the dynamic nature of the biotech sector, where financial agility and strategic foresight are key to navigating the industry's challenges and opportunities.
Cost of Revenue: Key Insights for GSK plc and Viridian Therapeutics, Inc.
Neurocrine Biosciences, Inc. vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Incyte Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Ligand Pharmaceuticals Incorporated
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Cost of Revenue: Key Insights for Alkermes plc and Ligand Pharmaceuticals Incorporated
Comparing Cost of Revenue Efficiency: HUTCHMED (China) Limited vs Viridian Therapeutics, Inc.
Cost of Revenue Trends: Agios Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Geron Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Viridian Therapeutics, Inc.